Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project

The ROADMAP Consortium

Research output: Contribution to journalArticle (Academic Journal)

282 Downloads (Pure)

Abstract

ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in the decision-making process for new treatments in Alzheimer’s disease, and to advance key concepts in disease and pharmacoeconomic modeling. ROADMAP identified key disease and patient outcomes for stakeholders to make informed funding and treatment decisions, provided advice on data integration methods and standards, and developed conceptual cost-effectiveness and disease models designed in part to assess whether early treatment provides long-term benefit.
Original languageEnglish
Pages (from-to)495-501
Number of pages7
JournalJournal of Alzheimer's Disease
Volume67
Issue number2
DOIs
Publication statusPublished - 22 Jan 2019

Keywords

  • Alzheimer’s disease
  • data sharing
  • data systems
  • health policy
  • patient outcome assessment
  • real-world clinical trialsq
  • systems integration

Fingerprint Dive into the research topics of 'Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project'. Together they form a unique fingerprint.

  • Cite this